|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | G01N 33/574 |
| (11) | Number of the document | 2596363 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11746191.3 |
| Date of filing the European patent application | 2011-07-18 | |
| (97) | Date of publication of the European application | 2013-05-29 |
| (45) | Date of publication and mention of the grant of the patent | 2017-01-18 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2011/062232 |
| Date | 2011-07-18 |
| (87) | Number | WO 2012/010552 |
| Date | 2012-01-26 |
| (30) | Number | Date | Country code |
| 10170008 | 2010-07-19 | EP |
| (72) |
DE HAAS, Sanne Lysbet, CH
DELMAR, Paul, CH
FOERNZLER, Dorothee, CH
KLAUSE, Ursula, DE
SCHERER, Stefan, US
|
| (73) |
F. Hoffmann-La Roche AG,
Grenzacherstrasse 124, 4070 Basel,
CH
|
| (54) | BLOOD PLASMA BIOMARKERS FOR BEVACIZUMAB COMBINATION THERAPIES FOR TREATMENT OF BREAST CANCER |
| BLOOD PLASMA BIOMARKERS FOR BEVACIZUMAB COMBINATION THERAPIES FOR TREATMENT OF BREAST CANCER |